Special report

The Amplatzer™ Cardiac Plug 2 for left atrial appendage occlusion: novel features and first-in-man experience

EuroIntervention 2013;8:1094-1098. DOI: 10.4244/EIJV8I9A167

Xavier Freixa
Xavier Freixa1, MD; Jason L. K. Chan1, MD; Apostolos Tzikas2, MD, PhD; Patrick Garceau1, MD; Arsène Basmadjian1, MD; Réda Ibrahim1*, MD
1. Department of Medicine, Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada; 2. St. Luke’s Hospital, Thessaloniki, Greece

Percutaneous left atrial appendage (LAA) closure is becoming a frequently performed procedure for patients with atrial fibrillation and high haemorrhagic risk. The Amplatzer™ Cardiac Plug (ACP) is one of the most commonly used devices for this purpose. Despite high success rate and low procedure risk associated with the ACP, a second generation of the device is now available. The new ACP has been designed to facilitate the implantation process, improve sealing performance and further reduce the risk of complications. The present report focuses on the novel features of the second generation of the Amplatzer™ Cardiac Plug (ACP 2 or ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

amplatzer cardiac plugatrial fibrillationleft atrial appendagestroke
Read next article
A modified technique of balloon anchoring for tricky stent delivery

Latest news